About WAMA Labs
WAMA Labs, located in close vicinity to The Linnaeus University in Kalmar, Sweden, is a modern state of the art facility.
Its founder Marie-Louise G Wadenberg (Ph D, Associate Professor) holds a PhD in experimental psychopharmacology with 25 years of active research experience, and more than 50 scientific publications in highly regarded International Scientific Journals. She has a solid experience in setting up & running in vivo laboratory screening tests/animal models (USA, Canada, Sweden), and is an internationally acknowledged expert on screening tests for assessment of drug antipsychotic activity (CAR test) and extrapyramidal side effect liability (catalepsy test). She is also well experienced in contract research and in the management of patent applications.
The company stands out internationally as it uses in-house built, custom made equipment for experimental testing in order to optimize the interaction between animal, equipment and pharmacology. It is our unique approach, based on solid experience with rodent behavior, that makes data accumulation optimally efficient and reliable.
Contact info: email@example.com
Currently going on
Head of WAMA Labs, Dr Marie-Louise Wadenberg is a former Recipient of an Investigator Award from the International Congress of Schizophrenia Research (ICOSR) organization. At a recent ICOSR-meeting (that also invited former Award Recipients to a reunion) in Orlando Florida, Dr Wadenberg presented data on the effects of the Alzheimer drug galantamine (alone and in the presence of low dose antipsychotic risperidone) in the attentional set-shifting test for cognitive functions.
In September, Dr Wadenberg is invited to present experimental data with cholinergic acting drugs, using tests for antipsychotic activity as well as cognitive functioning, at a meeting in Copenhagen, Denmark featuring several prominent speakers from USA, UK, Italy, Germany, Australia and Denmark.